Neuroscience Market Size, Share & Forecast 2025-2035
The Neuroscience market accounted for USD 43.75 Billion in 2024 and is expected to reach USD 80.5 Billion by 2035, growing at a CAGR of around 5.7% between 2025 and 2035.
Pharmaceuticals, biotechnology, medical devices, healthcare IT solutions, hospitals, telemedicine, and wellness services constitute an important component of healthcare commercialization. AI applications that trigger such change have come from AI-based clinical solutions that provide advancements in precision medicine or digital transformation in health. Therefore, as healthcare prioritizes value-based care and enhanced outcomes, remote patient monitoring systems, patient-specific treatment plans, and diagnostics will be increasingly in demand. The consumerization of medicine, however, does not cast away the expansion of the telehealth services market growth and trend in the adoption of wearable medical devices.
Key market drivers include the rise of chronic disease, aging populations, government initiatives for universal access to healthcare, and advances in healthcare technology. Challenges are arising, however, with high healthcare costs, stringent regulatory frameworks, data privacy concerns in digital health practices, and a global shortage in the healthcare workforce. Growth opportunities can be found in building healthcare data security on blockchain, drug discovery by artificial intelligence, expansion of the robotic-assisted surgery market, and personalized innovations in medicine. The evolution of clinical decision-making and operational efficiency is revolutionizing clinical decision-making and operational efficiency at hospitals and other healthcare facilities through the adoption of EHRs and AI-powered predictive analytics in patient care.
The Neuroscience market accounted for USD 43.75 Billion in 2024 and is expected to reach USD 80.5 Billion by 2035, growing at a CAGR of around 5.7% between 2025 and 2035.
The Home Vaccination market accounted for USD 3.49 Billion in 2024 and is expected to reach USD 7.27 Billion by 2035, growing at a CAGR of around 6.9% between 2025 and 2035.
The Baby Wipes market accounted for USD 6.09 Billion in 2024 and is expected to reach USD 10.83 Billion by 2035, growing at a CAGR of around 5.37% between 2025 and 2035.
The Neutropenia market accounted for USD 15.85 Billion in 2024 and is expected to reach USD 28.86 Billion by 2035, growing at a CAGR of around 5.6% between 2025 and 2035.
The Myasthenia Gravis Treatment market accounted for USD 1.86 Billion in 2024 and is expected to reach USD 4.18 Billion by 2035, growing at a CAGR of around 7.65% between 2025 and 2035.
The Hydrocolloid Dressing market accounted for USD 1.64 Billion in 2024 and is expected to reach USD 3.36 Billion by 2035, growing at a CAGR of around 6.74% between 2025 and 2035.
The Bioacoustics Sensing market accounted for USD 3.14 Billion in 2024 and is expected to reach USD 7.86 Billion by 2035, growing at a CAGR of around 8.7% between 2025 and 2035.
The Transdermal Patches market accounted for USD 8.32 Billion in 2024 and is expected to reach USD 14.38 Billion by 2035, growing at a CAGR of around 5.1% between 2025 and 2035.
The Trachoma Treatment market accounted for USD 561.9 Million in 2024 and is expected to reach USD 1162.21 Million by 2035, growing at a CAGR of around 6.83% between 2025 and 2035.
The STD Diagnostics market accounted for USD 11.58 Billion in 2024 and is expected to reach USD 25.14 Billion by 2035, growing at a CAGR of around 7.3% between 2025 and 2035.
The Empty IV Bags market accounted for USD 5.71 Billion in 2024 and is expected to reach USD 14.44 Billion by 2035, growing at a CAGR of around 8.8% between 2025 and 2035.
The Non-Surgical Rhinoplasty Market accounted for USD 815.69 million in 2024 and is expected to reach USD 1942.96 million by 2035, growing at a CAGR of around 8.21% between 2025 and 2035.
The Genomics in Cancer Care Market accounted for USD 21.05 billion in 2024 and is expected to reach USD 108.51 billion by 2035, growing at a CAGR of around 16.08% between 2024 and 2035.
The Diabetic Retinopathy market accounted for USD 9.63 Billion in 2024 and is expected to reach USD 19.65 Billion by 2035, growing at a CAGR of around 6.7% between 2025 and 2035.
The Birth Tourism market accounted for USD 297.40 Million in 2024 and is expected to reach USD 613.23 Million by 2035, growing at a CAGR of around 6.8% between 2025 and 2035.
The Bioequivalence Studies market accounted for USD 798.07 Million in 2024 and is expected to reach USD 1930.19 Million by 2035, growing at a CAGR of around 8.36% between 2025 and 2035
The Autoimmune Hemolytic Anemia Treatment Market accounted for USD 801.34 Million in 2024 and is expected to reach USD 1613.63 Million by 2035, growing at a CAGR of around 6.57% between 2025 and 2035.
The Adult Incontinence market accounted for USD 31.65 Billion in 2024 and is expected to reach USD 72.31 Billion by 2035, growing at a CAGR of around 7.8% between 2025 and 2035.
The Transthyretin Amyloidosis Treatment Market accounted for USD 6.78 Billion in 2024 and is expected to reach USD 29.04 Billion by 2035, growing at a CAGR of around 14.14% between 2025 and 2035.
The Rotator Cuff Treatment market accounted for USD 919.04 Million in 2024 and is expected to reach USD 1852.54 Million by 2035, growing at a CAGR of around 6.58% between 2025 and 2035.
The Retinal Laser Photocoagulation Market accounted for USD 268.8 Million in 2024 and is expected to reach USD 444.09 Million by 2035, growing at a CAGR of around 4.7% between 2025 and 2035.
The Research Antibodies Market accounted for USD 2.48 Billion in 2024 and is expected to reach USD 4.31 Billion by 2035, growing at a CAGR of around 5.14% between 2025 and 2035.
The Menopausal Hot Flashes market accounted for USD 15.68 Billion in 2024 and is expected to reach USD 28.55 Billion by 2035, growing at a CAGR of around 5.6% between 2025 and 2035.
The Congestive Heart Failure Drugs market accounted for USD 8.87 Billion in 2024 and is expected to reach USD 39.71 Billion by 2035, growing at a CAGR of around 14.6% between 2025 and 2035.
The Colposcopy Market accounted for USD 746.10 Million in 2024 and is expected to reach USD 1401.69 Million by 2035, growing at a CAGR of around 5.9% between 2025 and 2035.
The Pediatric Oral Care market accounted for USD 10.49 Billion in 2024 and is expected to reach USD 22.96 Billion by 2035, growing at a CAGR of around 7.38% between 2025 and 2035.
The Patient Lateral Transfer market accounted for USD 457.2 Million in 2024 and is expected to reach USD 1,203.8 Million by 2035, growing at a CAGR of around 9.2% between 2025 and 2035.
The Hysteroscopy Procedures Market accounted for USD 4.92 Billion in 2024 and is expected to reach USD 11.32 Billion by 2035, growing at a CAGR of around 7.87% between 2025 and 2035.
The Female External Catheter market accounted for USD 1.32 Billion in 2024 and is expected to reach USD 2.48 Billion by 2035, growing at a CAGR of around 5.9 % between 2025 and 2035.
The Insilico Clinical Trials market accounted for USD 3.72 Billion in 2024 and is expected to reach USD 8.82 Billion by 2035, growing at a CAGR of around 7.5% between 2025 and 2035.
The Bariatric Walker Market accounted for USD 1.53 Billion in 2024 and is expected to reach USD 3.25 Billion by 2035, growing at a CAGR of around 7.82% between 2025 and 2035.
The Wound Closure Strips market accounted for USD 257.23 Million in 2024 and is expected to reach USD 478.26 Million by 2035, growing at a CAGR of around 5.8% between 2025 and 2035.
The Actinic Keratosis Treatment market accounted for USD 6.65 Billion in 2024 and is expected to reach USD 14.44 Billion by 2035, growing at a CAGR of around 5.6% between 2025 and 2035.
The Ophthalmic Packaging market accounted for USD 12.72 Billion in 2024 and is expected to reach USD 33.49 billion by 2035, growing at a CAGR of around 9.2 % between 2025 and 2035.
The Cardiovascular Clinical Trials market accounted for USD 5.87 Billion in 2024 and is expected to reach USD 11.61 Billion by 2035, growing at a CAGR of around 6.4% between 2025 and 2035.
The T cell Lymphoma Market accounted for USD 2.23 Billion in 2024 and is expected to reach USD 5.36 Billion by 2035, growing at a CAGR of around 8.3% between 2025 and 2035.
The Microbiome Treatment market accounted for USD 1.03 billion in 2024 and is expected to reach USD 6.73 billion by 2035, growing at a CAGR of around 18.6% between 2025 and 2035.
The IVF Services Market accounted for USD 22.4 Billion in 2024 and is expected to reach USD 51.7 Billion by 2035, growing at a CAGR of around 7.9% between 2025 and 2035.
The Dried Blood Spot Collection Cards market accounted for USD 403.8 Million in 2024 and is expected to reach USD 676.3 Million by 2035, growing at a CAGR of around 4.8% between 2025 and 2035.
The Immuno-Oncology Clinical Trials Market accounted for USD 9.26 Billion in 2024 and is expected to reach USD 33.19 Billion by 2035, growing at a CAGR of around 12.3% between 2025 and 2035.
The Surgical Sphincteroplasty market accounted for USD 1.73 Billion in 2024 and is expected to reach USD 3.72 Billion by 2035, growing at a CAGR of around 7.2% between 2025 and 2035.
The Angina Pectoris Drugs market accounted for USD 12.48 Billion in 2024 and is expected to reach USD 22.26 Billion by 2035, growing at a CAGR of around 5.4% between 2025 and 2035.
The Proteinase K Market accounted for USD 4.88 Billion in 2024 and is expected to reach USD 12.15 Billion by 2035, growing at a CAGR of around 8.65% between 2025 and 2035.
The Intravenous Iron Drugs Market accounted for USD 3.45 Billion in 2024 and is expected to reach USD 8.73 Billion by 2035, growing at a CAGR of around 8.81% between 2025 and 2035.
The Anti-Fatigue Cosmetics market accounted for USD 2.83 Billion in 2024 and is expected to reach USD 4.94 Billion by 2035, growing at a CAGR of around 5.2% between 2025 and 2035.
The Cholecystectomy Market accounted for USD 49.3 Million in 2024 and is expected to reach USD 102.7 Million by 2035, growing at a CAGR of around 6.9% between 2025 and 2035.
The Sterility Testing Market accounted for USD 1.51 Billion in 2024 and is expected to reach USD 4.22 Billion by 2035, growing at a CAGR of around 9.8% between 2025 and 2035.
The MicroRNA Biomarker Market accounted for USD 765.8 Million in 2024 and is expected to reach USD 2770.4 Million by 2035, growing at a CAGR of around 12.4% between 2025 and 2035.
The Thyroid Function Test market accounted for USD 5.1 Billion in 2024 and is expected to reach USD 9.78 Billion by 2035, growing at a CAGR of around 6.1% between 2025 and 2035.
The Migraine Treatment Market accounted for USD 6.5 Billion in 2024 and is expected to reach USD 16.94 Billion by 2035, growing at a CAGR of around 9.1% between 2025 and 2035.
Our analysts are ready to help you immediately.
We have received your request. We value your interest in our services and are pleased to inform you that our dedicated research specialist will be reaching out to you shortly. If you have any further questions or require additional assistance, feel free to let us know via-